News › Clinical Practice, Industry News, Patient Care

Refine USA’s Rejuvapen NXT Microneedling System Earns FDA Clearance

April 16, 2020

Refine USA has been granted a class 2 medical clearance from the FDA for its medical grade microneedling device, Rejuvapen NXT. This recent clearance has expanded its intended use to facial wrinkles.
The Rejuvapen NXT has passed multiple electrical and safety tests for biocompatibility, including testing for irritation, cytotoxicity and sensitization, ensuring none of the materials used are harmful to the patient. These tests include design verification and validation testing. The product is also certified according to ISO/IEC Guide 17067 and in accordance with ANSI/AAMI ES60601.
Click here to learn more about the Rejuvapen NXT >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • PDGF, Regenerative Medicine and the Questions Med Spas Can’t Ignore
    • Medicare GLP-1 Bridge Program Launches July 1, Expanding Access for Some Patients
    • Universal Healthcare Consulting Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • DAW Systems Earns First Artificial Intelligence Accreditation from DirectTrust
    • Estée Lauder Executive’s Death Linked to Pulmonary Embolism Following Cosmetic Filler Injection
Advertisement